WallStreetZenWallStreetZen

NASDAQ: OTRK
Ontrak Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for OTRK

Based on 1 analyst offering 12 month price targets for Ontrak Inc.
Min Forecast
$4.00+809.09%
Avg Forecast
$4.00+809.09%
Max Forecast
$4.00+809.09%

Should I buy or sell OTRK stock?

Based on 1 analyst offering ratings for Ontrak Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OTRK stock forecasts and price targets.

OTRK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-05

1 of 1

Forecast return on equity

Is OTRK forecast to generate an efficient return?

Forecast return on assets

Is OTRK forecast to generate an efficient return on assets?

OTRK revenue forecast

What is OTRK's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$18.8M+60.24%
Avg 2 year Forecast
$29.9M+155.51%
Avg 3 year Forecast
$42.4M+262.22%
OTRK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OTRK revenue growth forecast

How is OTRK forecast to perform vs Health Information Services companies and vs the US market?
Company
53.31%
Industry
13.33%
Market
10.3%
OTRK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OTRK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OTRK vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
OTRK$0.44$4.00+809.09%Strong Buy
CMAX$3.25$33.20+921.54%Hold
ICCT$1.24N/AN/A
ONMD$0.68N/AN/A
ATPC$0.23N/AN/A
View Top Health Information Service Stocks

Ontrak Stock Forecast FAQ

Is Ontrak Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: OTRK) stock is to Strong Buy OTRK stock.

Out of 1 analyst, 1 (100%) are recommending OTRK as a Strong Buy, 0 (0%) are recommending OTRK as a Buy, 0 (0%) are recommending OTRK as a Hold, 0 (0%) are recommending OTRK as a Sell, and 0 (0%) are recommending OTRK as a Strong Sell.

If you're new to stock investing, here's how to buy Ontrak stock.

What is OTRK's revenue growth forecast for 2024-2026?

(NASDAQ: OTRK) Ontrak's forecast annual revenue growth rate of 53.31% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 13.33%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.3%.

Ontrak's revenue in 2024 is $11,714,000.On average, 1 Wall Street analysts forecast OTRK's revenue for 2024 to be $517,374,365, with the lowest OTRK revenue forecast at $517,374,365, and the highest OTRK revenue forecast at $517,374,365. On average, 1 Wall Street analysts forecast OTRK's revenue for 2025 to be $824,987,467, with the lowest OTRK revenue forecast at $824,987,467, and the highest OTRK revenue forecast at $824,987,467.

In 2026, OTRK is forecast to generate $1,169,536,192 in revenue, with the lowest revenue forecast at $1,169,536,192 and the highest revenue forecast at $1,169,536,192.

What is OTRK's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: OTRK) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of N/A.

What is OTRK's Price Target?

According to 1 Wall Street analyst that have issued a 1 year OTRK price target, the average OTRK price target is $4.00, with the highest OTRK stock price forecast at $4.00 and the lowest OTRK stock price forecast at $4.00.

The Wall Street analyst predicted that Ontrak's share price could reach $4.00 by Dec 5, 2024. The average Ontrak stock price prediction forecasts a potential upside of 809.09% from the current OTRK share price of $0.44.

What is OTRK's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: OTRK) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.